Amphastar Pharmaceuticals Reports Net Revenues of $63.9 Million for the Third Quarter Ended September 30, 2015

Go back to Amphastar Pharmaceuticals Reports Net Revenues of $63.9 Million for the Third Quarter Ended September 30, 2015

Amphastar Pharma (AMPH) Reports Q3 Loss of $0.01/Share

November 12, 2015 4:24 PM EST

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $63.9 million, versus $59.7 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More